Patents by Inventor Michael Moazami

Michael Moazami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THIENOPYRROLE COMPOUNDS
    Publication number: 20250049780
    Abstract: The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of an autoimmune disease and/or inflammatory condition, including systemic lupus erythematosus and cutaneous lupus erythematosus.
    Type: Application
    Filed: July 12, 2024
    Publication date: February 13, 2025
    Inventors: Stephen E. Ammann, Eda Y. Canales, Weng K. Chang, Henok H. Kinfe, Scott E. Lazerwith, Michael L. Mitchell, Yasamin Moazami, Scott D. Schroeder, Daniel G. Shore
  • ANTI-C9ORF72 OLIGONUCLEOTIDES AND RELATED METHODS
    Publication number: 20230295629
    Abstract: The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
    Type: Application
    Filed: March 3, 2023
    Publication date: September 21, 2023
    Inventors: Robert H. Brown, Jr., Jonathan K. Watts, Helene Tran, Michael Moazami
  • Anti-C9ORF72 oligonucleotides and related methods
    Patent number: 11629347
    Abstract: The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: April 18, 2023
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventors: Robert H. Brown, Jr., Jonathan K. Watts, Helene Tran, Michael Moazami
  • ANTI-C9ORF72 OLIGONUCLEOTIDES AND RELATED METHODS
    Publication number: 20200385723
    Abstract: The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
    Type: Application
    Filed: May 6, 2020
    Publication date: December 10, 2020
    Inventors: Robert H. Brown, JR., Jonathan K. Watts, Helene Tran, Michael Moazami